Loading...

mosque
partly-cloudy
°C,
العربية
Health - COVID-19

Japan picks COVID-19 drug candidates to get research funds

September 07, 2021 / 10:57 AM
Image for the title: Japan picks COVID-19 drug candidates to get research funds
download-img
Sharjah24 – Reuters: Japan has selected three candidates for COVID-19 treatments to receive subsidies for clinical trials, the health ministry said on Tuesday.
The drugs are AstraZeneca Plc's antibody treatment AZD7442, Shionogi & Co's protease inhibitor S-217622, and Fujifilm Holding Corp's antiviral favipiravir, known commercially as Avigan.
September 07, 2021 / 10:57 AM

Related Topics

More on this Topic

Image for the title: Japan to provide millions more vaccine doses to Taiwan
03 years
COVID-19
Japan to provide millions more vaccine doses to Taiwan
Image for the title: Zuckerberg says US pressure on Covid-19 posts was 'wrong'
03 months
COVID-19
Zuckerberg says US pressure on Covid-19 posts was 'wrong'
Image for the title: Covid restrictions brought back at Tour de France
05 months
COVID-19
Covid restrictions brought back at Tour de France
Image for the title: COVID-19 still kills 1,700 a week: WHO
05 months
COVID-19
COVID-19 still kills 1,700 a week: WHO

Rotate For an optimal experience, please
rotate your device to portrait mode.